Literature DB >> 15294200

Why do restless legs occur at rest?--pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2).

C Trenkwalder1, W Paulus.   

Abstract

Restless legs syndrome (RLS) is a heterogeneous disorder encompassing genetically caused types with early onset and acquired varieties occurring later in life. Genetic studies in the near future will most likely discover more than one causative gene. The acquired cases too have different etiologies ranging from idiopathic types to secondary forms with uremia, iron depletion, polyneuropathy and others. Here we aim to correlate typical RLS symptoms, such as the sensory symptoms at rest, the reduction of the complaint in response to movement or other physical stimuli, the dominant involvement of the legs, pain, circadian rhythm, and the responsiveness to dopaminergic drugs with neurophysiological features of the central nervous system. We outline the complexity of the neural structures involved and their connections. A diversity of hypothetical affections of different neuronal levels might lead to various combinations of RLS symptomatology. No single pathophysiological explanation has yet been developed that covers all clinical features.

Entities:  

Mesh:

Year:  2004        PMID: 15294200     DOI: 10.1016/j.clinph.2004.01.031

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  26 in total

1.  Use of near-infrared light to reduce symptoms associated with restless legs syndrome in a woman: a case report.

Authors:  Ulrike H Mitchell
Journal:  J Med Case Rep       Date:  2010-08-23

Review 2.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

3.  Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment.

Authors:  Birgit Högl; Walter Paulus; Peter Clarenbach; Claudia Trenkwalder
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

4.  Diurnal H-reflex variation in mice.

Authors:  Jonathan S Carp; Ann M Tennissen; Xiang Yang Chen; Jonathan R Wolpaw
Journal:  Exp Brain Res       Date:  2005-09-07       Impact factor: 1.972

5.  Double-blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome.

Authors:  Fatta B Nahab; Elizabeth L Peckham; Mark Hallett
Journal:  Neurology       Date:  2008-09-16       Impact factor: 9.910

Review 6.  [Neurophysiological and neuroimaging studies for restless legs syndrome and periodic leg movement disorder].

Authors:  S Happe; W Paulus
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

7.  High prevalence of restless legs syndrome in somatoform pain disorder.

Authors:  Martin Aigner; Wolfgang Prause; Marion Freidl; Maria Weiss; Shahriar Izadi; Michael Bach; Bernd Saletu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-02       Impact factor: 5.270

8.  Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption.

Authors:  Robert R Edwards; Phillip J Quartana; Richard P Allen; Seth Greenbaum; Christopher J Earley; Michael T Smith
Journal:  Sleep Med       Date:  2011-05-12       Impact factor: 3.492

9.  A comparison of glycemic control, sleep, fatigue, and depression in type 2 diabetes with and without restless legs syndrome.

Authors:  Norma G Cuellar; Sarah J Ratcliffe
Journal:  J Clin Sleep Med       Date:  2008-02-15       Impact factor: 4.062

10.  Defining the boundaries of the response of sleep leg movements to a single dose of dopamine agonist.

Authors:  Mauro Manconi; Raffaele Ferri; Thom R Feroah; Marco Zucconi; Luigi Ferini-Strambi
Journal:  Sleep       Date:  2008-09       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.